Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CCL vs GSK✓SelectedUSD · GSKCCL vs GSK performance historyLatest closeAs of+2.88%11/18
Stock and ETF performance explorer

CCL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.2%
GSK return
+42.7%
Excess return
-1.4%
Maximum drawdown
-72.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.9%-1.3%+4.2%+3.2%
7D-5.6%-3.1%-2.4%-4.8%
30D+10.1%-0.9%+11.0%+10.3%
3M+6.8%-4.2%+10.9%+7.8%
6M+17.5%-1.6%+19.1%+17.7%
YTD-3.1%+2.6%-5.7%-3.0%
1Y+14.9%+6.2%+8.6%+14.3%
3Y+100.0%+55.0%+45.1%+75.1%
5Y+41.2%+42.8%-1.6%+13.7%
All+41.2%+42.7%-1.4%+13.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling